Subscribe to RSS
DOI: 10.1055/s-0041-1741448
Knowledge, Attitude, and Practices Related to the SARS-CoV-2 Pandemic among Women Seeking Contraceptive Methods
Conhecimento, atitude e práticas relacionadas à pandemia de SARS-CoV-2 entre mulheres que buscam métodos anticoncepcionaisAbstract
Objective To determine knowledge, attitude, and preventive (KAP) practices towards the SARS-CoV-2 (COVID-19) pandemic among women in reproductive age seeking to use copper or hormonal intrauterine devices (IUD/LNG-IUS).
Methods We conducted a cross-sectional study in which we applied a questionnaire on 400 women about KAP practices on COVID-19 at the University of Campinas, Campinas, SP, Brazil, from May to August 2020.
Results The mean (±SD) age of the women was 30.8 ± 7.9 years, and 72.8% of them reported being pregnant at least once. Most women (95%) had heard or read about COVID-19, and their main sources of information were television (91%) and government websites (53%). However, 53% of the women had doubts about the veracity of the information accessed.
Conclusion Women without a partner and with > 12 years of schooling had more information about COVID-19 and on its impact on new pregnancy, and those from high socioeconomic status had a higher chance of maintaining physical distance. Safety, effectiveness, comfort, and absence of hormone in the contraceptive method (in the case of TCu380A IUD) were the main reasons for the participants to seek the service during the pandemic, and the possibility to stop menstrual bleeding was the main reason to choose the LNG-IUS.
Resumo
Objetivo Determinar o conhecimento, atitude e práticas preventivas (CAP) em relação à pandemia de SARS-CoV-2 (Covid-19) entre mulheres em idade reprodutiva que buscam usar dispositivo intrauterino com cobre (DIU TCu 380) ou sistema intrauterino liberador de levonorgestrel (SIU-LNG).
Métodos Foi realizado um estudo transversal e um questionário foi aplicado a 400 mulheres para conhecer o CAP sobre o COVID-19 na Universidade Estadual de Campinas, Campinas, SP, Brasil, no período de maio a agosto de 2020.
Resultados A média (±DP) de idade das mulheres foi de 30,8 ± 7,9 anos, e 72,8% delas relataram ter engravidado pelo menos uma vez. A maioria das mulheres (95%) tinha ouvido ou lido sobre a a Covid-19, e suas principais fontes de informação foram a televisão (91%) e sites do governo (53%). Porém, 53% das mulheres tinham dúvidas a respeito da veracidade das informações acessadas.
Conclusão Mulheres sem companheiro e com mais de 12 anos de escolaridade tiveram mais informações sobre a COVID-19 e sobre o seu impacto em uma nova gravidez, e aquelas de nível socioeconômico alto tiveram maior chance de manter distância física. Segurança, eficácia, conforto e ausência de hormônio no método anticoncepcional (no caso do DIU TCu380A) foram os principais motivos para as participantes procurarem o serviço durante a pandemia, e a possibilidade de controlar o sangramento menstrual abundante foi o principal motivo para a escolha do SIU-LNG.
Keywords
COVID-19 - knowledge - attitudes - practices - copper IUD - levonorgestrel intrauterine system - socio demographic characteristicsPalavras-chave
COVID-19 - conhecimento - atitudes - práticas - DIU de cobre - sistema intrauterino de levonorgestrel - características sociodemográficasContributions
All authors contributed to the design of the study and were involved in the data collection, data analysis and/or interpretation. Also, all authors contributed to manuscript writing/substantive editing and review and approved the final draft of the manuscript.
Publication History
Received: 21 January 2021
Accepted: 01 October 2021
Article published online:
27 May 2022
© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Bahamondes L, Makuch MY. Family planning: an essential health activity in the pandemic of SARS-CoV-2. Eur J Contracept Reprod Health Care 2020; 25 (04) 319-320 DOI: 10.1080/13625187.2020.1768368.
- 2 Johns Hopkins University (JHU). Center for Systems Science and Engineering (CSSE). COVID-19 Dashboard [Internet]. 2020 [cited 2020 May 15]. Available from: https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
- 3 World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2020 [cited 2020 Jun 30]. Available from: http://covid19.who.int/
- 4 International Planned Parenthood Federation. IMAP statement on COVID-19 and sexual and reproductive health and rights [Internet]. 2020 [cited 2020 Jun 18]. Available from: https://www.ippf.org/resource/imap-statement-covid-19-and-sexual-and-reproductive-health-and-rights
- 5 Rasmussen SA, Lyerly AD, Jamieson DJ. Delaying pregnancy during a public health crisis - examining public health recommendations for Covid-19 and beyond. N Engl J Med 2020; 383 (22) 2097-2099 DOI: 10.1056/NEJMp2027940.
- 6 Kumar N. COVID 19 era: a beginning of upsurge in unwanted pregnancies, unmet need for contraception and other women related issues. Eur J Contracept Reprod Health Care 2020; 25 (04) 323-325 DOI: 10.1080/13625187.2020.1777398.
- 7 United Nations Population Fund (UNFPA). Impact of the COVID-19 pandemic on family planning and ending gender-based violence, female genital mutilation and child marriage. Interim Technical Note [Internet]. 2020 [2020 Jul 12]. Available from: https://www.unfpa.org/sites/default/files/resource-pdf/COVID-19_impact_brief_for_UNFPA_24_April_2020_1.pdf
- 8 Short M, Bitzer J, Rowlands S. Testing times. Eur J Contracept Reprod Health Care 2020; 25 (03) 167-168 DOI: 10.1080/13625187.2020.1754036.
- 9 Riley T, Sully E, Ahmed Z, Biddlecom A. Estimates of the potential impact of the COVID-19 pandemic on sexual and reproductive health in low- and middle-income countries. Int Perspect Sex Reprod Health 2020; 46: 73-76 DOI: 10.1363/46e9020.
- 10 Ferreira-Filho ES, de Melo NR, Sorpreso ICE, Bahamondes L, Simões RDS, Soares-Júnior JM. et al. Contraception and reproductive planning during the COVID-19 pandemic. Expert Rev Clin Pharmacol 2020; 13 (06) 615-622 DOI: 10.1080/17512433.2020.1782738.
- 11 Nanda K, Lebetkin E, Steiner MJ, Yacobson I, Dorflinger LJ. Contraception in the Era of COVID-19. Glob Health Sci Pract 2020; 8 (02) 166-168 DOI: 10.9745/GHSP-D-20-00119.
- 12 Weinberger M, Hayes B, White J, Skibiak J. Doing things differently: what it would take to ensure continued access to contraception during COVID-19. Glob Health Sci Pract 2020; 8 (02) 169-175 DOI: 10.9745/GHSP-D-20-00171.
- 13 Ministry of Public Health, United Nations Children's Fund (UNICEF). KAP survey on COVID 19- response [Internet]. 2020 . [cited 2020 Apr 2]. Available from: https://www.surveymonkey.com/r/gy_kapsurvey
- 14 World Health Organization. Country & Technical Guidance - Coronavirus disease (COVID-19) [Internet]. 2020 [cited 2020 May 2]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance
- 15 Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C. et al. UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107 DOI: 10.1136/bmj.m2107.
- 16 Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (25) 769-775 DOI: 10.15585/mmwr.mm6925a1.
- 17 Faden RR, Kass NE. HIV, AIDS and childbearing: public policy, private lives. New York: Oxford University Press; 1996
- 18 Takemoto MLS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L. et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet 2020; 151 (01) 154-156 DOI: 10.1002/ijgo.13300.
- 19 Ali SH, Foreman J, Tozan Y, Capasso A, Jones AM, DiClemente RJ. Trends and predictors of COVID-19 information sources and their relationship with knowledge and beliefs related to the pandemic: Nationwide cross-sectional study. JMIR Public Health Surveill 2020; 6 (04) e21071 DOI: 10.2196/21071.
- 20 Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med 2020; 382 (18) 1679-1681 DOI: 10.1056/NEJMp2003539.
- 21 Anderson G, Frank JW, Naylor CD, Wodchis W, Feng P. Using socioeconomics to counter health disparities arising from the covid-19 pandemic. BMJ 2020; 369: m2149 DOI: 10.1136/bmj.m2149.
- 22 The Lancet. COVID-19 in Brazil: “So what?”. Lancet 2020; 395 (10235): 1461 DOI: 10.1016/s0140-6736(20)31095-3.
- 23 Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med 2020; 8 (07) 659-661 DOI: 10.1016/S2213-2600(20)30234-4.
- 24 Dorn AV, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet 2020; 395 (10232): 1243-1244 DOI: 10.1016/S0140-6736(20)30893-X.
- 25 Muñoz-Price LS, Nattinger AB, Rivera F, Hanson R, Gmehlin CG, Perez A. et al. Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw Open 2020; 3 (09) e2021892 DOI: 10.1001/jamanetworkopen.2020.21892.
- 26 Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE. et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012; 366 (21) 1998-2007 DOI: 10.1056/NEJMoa1110855.
- 27 Ti AJ, Roe AH, Whitehouse KC, Smith RA, Gaffield ME, Curtis KM. Effectiveness and safety of extending intrauterine device duration: a systematic review. Am J Obstet Gynecol 2020; 223 (01) 24-35.e3 DOI: 10.1016/j.ajog.2020.01.014.
- 28 Faculty of Sexual and Reproductive Healthcare. FSRH CEU recommendation on extended use of the etonogestrel implant and 52mg levonorgestrel-releasing intrauterine system during COVID restrictions [Internet]. London: FSRH; 2020 [cited 2020 May 2]. Available from: https://www.fsrh.org/documents/fsrh-ceu-recommendation-on-extended-use-of-the-etonogestrel/
- 29 American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetricians-gynecologists [Internet]. Washington (DC): ACOG; 2020 [cited 2020 Jun 15]. Available from: https://www.acog.org/clinical-information/physician-faqs/covid19-faqs-for-ob-gyns-gynecology
- 30 Cheng C, Barceló J, Hartnett AS, Kubinec R, Messerschmidt L. COVID-19 government response event dataset (CoronaNet v.1.0). Nat Hum Behav 2020; 4 (07) 756-768 DOI: 10.1038/s41562-020-0909-7.